10x Genomics, Inc. TXG Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.66M+48.0% | -$43.54M+42.9% | -$76.32M+9.8% | -$84.6M+46.1% | -$157.04M+14.0% | ||
| $38.13M+5.3% | $36.2M+3.8% | $34.88M+4.0% | $33.55M-3.3% | $34.71M-3.3% | ||
| $100.68M-7.7% | $109.12M-6.3% | $116.44M-6.7% | $124.76M-8.1% | $135.7M-3.6% | ||
| $127.82M-6.0% | $136.05M— | —— | —— | —— | ||
| $5.64M-5.0% | $5.94M-13.7% | $6.87M-31.8% | $10.08M-11.4% | $11.38M-8.2% | ||
| -$12.86M+4.3% | -$13.44M+78.7% | -$63.23M-8.9% | -$58.04M-28.5% | -$45.16M-38.4% | ||
| -$2.04M-130% | $6.8M-25.1% | $9.08M+5.3% | $8.62M-11.1% | $9.7M-11.1% | ||
| $113.22M-12.8% | $129.9M+276% | $34.55M+93.1% | $17.89M-15.9% | $21.28M+240% | ||
| $122.18M-6.1% | $130.12M+59.4% | $81.65M+43.6% | $56.88M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.